BioSpace News Archive

April 11 is World Parkinson’s Day, designed to raise awareness of Parkinson’s disease. Parkinson’s is a progressive disease of the nervous system that affects movement.

The German company is investing $100 million in expanding its manufacturing campus, which will add at least 445 new jobs to its current 100-plus staffing by the time it’s completed in 2022.

The loss of patent protection on two drugs is forcing Gilead Sciences to terminate about 20 percent of its sales team, according to reports.

The investment, which includes $225 million from Vida Ventures and TPG, as well as $10 million from AskBio’s founders and board members, is earmarked to advance and expand clinical trials.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.

Bio-Optronics unveiled the launch of CCTrialSuite, a comprehensive set of integrated, patient-centric clinical research management products to further streamline research operations while maintaining a high degree of compliance.

There is a war going on in the health care industry and the enemy is winning. That enemy is bacteria, fungi and other pathogens that have become resistant to treatment with conventional medicines.

Heidelberg Pharma AG reported on the first three months of fiscal year 2019 (1 December 2018 - 28 February 2019) and the Group’s financial figures.

Ultragenyx Pharmaceutical Inc. announced that management and external experts will provide an update to the investment community on the global commercial launch of Crysvita®, the company’s gene therapy programs and platform including manufacturing capabilities, and preclinical data on the next three Investigational New Drug applications the company plans to submit to the U.S. Food and Drug Administration.